Nanotoxicology plays a pivotal role in revolutionizing diagnostics within the pharmaceutical industry. With the advent of nanotechnology, the development and utilization of nanomaterials in diagnostic applications have surged. These nano-sized materials exhibit unique properties that enable precise interactions at the molecular and cellular levels. In the realm of diagnosis, nanotoxicology becomes crucial for evaluating the potential adverse effects of these nanomaterials on living organisms. Understanding the toxicity of nanoparticles is paramount to ensuring the safety and efficacy of diagnostic tools.
Researchers are investigating the interactions between nanoparticles and biological systems, exploring how these interactions might influence cellular functions. By comprehensively studying nanotoxicity, the pharmaceutical industry can design and implement innovative diagnostic strategies that leverage the advantages of nanomaterials while minimizing potential risks to patients. This interdisciplinary approach, combining nanotechnology and toxicology, not only propels advancements in diagnostic precision but also underscores the commitment to patient safety in the ever-evolving landscape of pharmaceutical innovation.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico